Level 3's global network selected by Courtagen Life Sciences to accelerate delivery of data
Jan 17, 2013 (M2 EQUITYBITES via COMTEX) --
Provider of communication services Level 3 Communications Inc (NYSE:LVLT) announced on Wednesday that Courtagen Life Sciences Inc, a life sciences company and clinically certified genetic testing lab, is using Level 3's secure, efficient network solutions to directly download and transmit massive amounts of data to generate clinically actionable results for patients.
Financial details of this deployment were not available.
Level 3 said that its network supports Courtagen's proprietary platform, ZiPhyr, which uses several databases and algorithm metrics to determine the pathogenicity or clinical relevance of genetic mutations in patient DNA. The system allows clinicians to generate results from a patient sample in days versus months.
Courtagen is using Level 3 Ethernet Private Line service to transport data to Amazon Web Services (AWS) via AWS Direct Connect, which gives enterprises a consistent, resilient network experience through dedicated connectivity provided by Level 3 to access enterprise resources. This capability reportedly enables Courtagen to securely and more quickly download and transmit the massive amounts of data required to generate actionable patient results.
Comments on this story may be sent to firstname.lastname@example.org
[ Back To TMCnet.com's Homepage ]